Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.
Stock data | 2024 | Change |
---|---|---|
Price | $0.29380439972088584 | N/A |
Market Cap | $29.80M | N/A |
Shares Outstanding | 101.42M | N/A |
Employees | 249.00 | N/A |